IL17A and alopecia: In addition, there was a reduction of mouse neutrophil infiltration in the skin after secukinumab treatment, as well as prevention of alopecia by the removal of neutrophils with anti-Ly6G treatment, suggesting that alopecia results from the recruitment of murine neutrophils by IL-17.